NNovo Nordisk Read More FDA GLP-1 Warning Adds Rare Vision Risk to Drug Labels — JournalArta Global2026-11-11 Business · Companies The FDA is requiring makers of several GLP-1 medicines to add a warning about a…
NNovo Nordisk Read More FDA Orders Blindness Risk Warning on Ozempic, Zepbound — JournalArta Global2026-11-10 The US Food and Drug Administration on Monday ordered GLP-1 weight-loss and diabetes drugs to carry a warning…
NNovo Nordisk Read More FDA adds warning for rare vision loss to popular GLP-1s2026-11-10 The FDA will now require makers of GLP-1s like Ozempic and Zepbound to add a warning to their…
NNovo Nordisk Read More FDA adds warning for rare vision loss to popular GLP-1s2026-11-09 The FDA will now require makers of GLP-1s like Ozempic and Zepbound to add a warning to their…
DDSV Read More Bear of the Day: DSV (DSDVY) |2026-09-05 The transportation and logistics market has experienced a volatile operating environment this year as geopolitical tensions, elevated energy…
GGreenland Read More How narwhal ‘scientists’ track Arctic warming2026-08-26 The fight against climate change has a new, spiral-tusked ally: the narwhal. In a study published in Science…
BBerlin Read More Berlin Attack Sparks German Blame Clash2026-08-01 Islam Times – German officials are trading blame after the suspect behind last weekend’s deadly Berlin attack was…
BBerlin Read More Berlin’s Delay Triggers Direct EU Pay Enforcement: IT Sector Most at Risk from New Burden of Proof2026-06-29 German companies must now defend themselves against pay discrimination claims under direct EU law after the government failed…
NNovo Nordisk Read More Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke2026-05-26 The Novo Nordisk study POSEIDON – including 18,904 patients across 18 countries – showed that cardiovascular (CV) inflammation…